Postmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer Disease | Zendy

Sudha Seshadri | Zendy; Gwen L. Zornberg | Zendy; Laura E. Derby | Zendy; Marian Wald Myers | Zendy; Hershel Jick | Zendy; David A. Drachman | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Postmenopausal Estrogen Replacement Therapy and the Risk of Alzheimer Disease

Author(s) -

Sudha Seshadri,

Gwen L. Zornberg,

Laura E. Derby,

Marian Wald Myers,

Hershel Jick,

David A. Drachman

Publication year - 2001

Publication title -

archives of neurology

Language(s) - English

Resource type - Journals

eISSN - 1538-3687

pISSN - 0003-9942

DOI - 10.1001/archneur.58.3.435

Subject(s) - medicine , odds ratio , estrogen , confidence interval , menopause , cohort , cohort study , population , nested case control study , hormone replacement therapy (female to male) , case control study , gynecology , obstetrics , testosterone (patch) , environmental health

Previous studies have examined the relation between postmenopausal estrogen replacement therapy (ERT) and the risk of Alzheimer disease (AD). The findings have been inconsistent, since some studies have been interpreted as showing a protective effect while others have reported no effect.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research